Letermovir has been tested in CMV infected patients with allogeneic stem cell transplants and may also be useful for other patients with a compromised immune system such as those with organ transplants or HIV infections
also known as FCE-26743 and EMD-1195686
H3O4P/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10
Negative inotropic effects of diadenosine tetraphosphate are mediated by protein kinase C and phosphodiesterases stimulation in the rat heart
6-bis(dimethylamino)-2-({4-[4-(trifluoromethyl)benzamido]phenyl}methyl)pyrimidin-5-yl]acetic acid
α-Tocopherol-d6 acetate Catalog No.:M24573-C Letermovir has been tested inProduct information CAS Number: 143731 16 2 Molecular Weight: 478. 78 Formula: C31H52O3 Chemical Name: (2R) 5,7 di(H)methyl 2,8 dimethyl 2 [(4R,8R) 4,8,12 trimethyltridecyl] 3,4 dihydro 2H 1 benzopyran 6 yl acetate Smiles: [2H]C([2H])([2H])C1=C(OC(C)=O)C(=C(C)C2O[C@@](C)(CCC1=2)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C([2H])([2H])[2H] InChiKey: ZAKOWWREFLAJOT JALLZHECSA N InChi: InChI=1S C31H52O3 c1 21(2)13 10 14 22(3)15 11 16 23(4)17 12 19 31(9)20 18 28